BOT 1.41% 35.0¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-35

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 381 Posts.
    lightbulb Created with Sketch. 168
    You got to be in it to win it.

    As long as fundamentals don't change, BOT's shareholders will win big.

    Buy volume is very low, but you can also see that no one is willing to sell hence the reason we are flat lining.

    Once positive announcement and we are off.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.005(1.41%)
Mkt cap ! $707.4M
Open High Low Value Volume
36.0¢ 36.0¢ 35.0¢ $230.9K 653.8K

Buyers (Bids)

No. Vol. Price($)
6 89180 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 138744 8
View Market Depth
Last trade - 10.50am 27/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.